期刊文献+

氯吡格雷对人胃黏膜上皮细胞增殖作用的影响及其机制的研究 被引量:3

The mechanim of Clopidogrel suppresses the proliferation of human gastric epithelial GES-1 cells
下载PDF
导出
摘要 目的探讨氯吡格雷(Clopidogrel)对人胃黏膜上皮细胞(GES-1)增殖作用的影响及其机制。方法建立GES-1单层细胞模型,将细胞分为阴性对照组、氯吡格雷24 h干预组、氯吡格雷48 h干预组、氯吡格雷72 h干预组,采用MTT比色法和流式细胞术检测各组细胞增殖、凋亡情况;采用Western blotting检测各细胞组紧密连接蛋白Occludin的表达量。结果与阴性对照组相比,氯吡格雷24 h干预组、氯吡格雷48 h干预组、氯吡格雷72 h干预组的细胞增殖明显受到抑制(P<0.05);Western blotting结果显示:与阴性对照组相比,后三组的Occludin表达下降。结论在GES-1细胞模型中,氯吡格雷可能通过降低Occludin的表达,从而损伤GES-1细胞。 Objective To investigate the effects of Clopidogrel on the proliferation of human gastric epithelial GES-1 cells and to clarify the damage mechanism of Clopidogrel in human gastric epithelial GES-I cells. Methods GES-I cells were cultured in vitro. Then the GES-1 cells were divided into four groups: control group, Clopidogrel group (24 h) , Clopidogrel group (48 h) , Clopidogrel group (72 h) , the reduced proliferation rates and apoptosis rates of GES-1 cells in tbur groups were examined by methyl thiazolyl tetrazolium (MTT) assay and Flow cytometry; the expression of Occlu- din protein in GES-1 cells were detected by Western blotting. Results The result of MTT showed that compared with control group, the proliferation of GES-1 cells was inhibited in other three groups (P 〈 0.05) ; Flow cytometry analysis indicated that the apoptosis rate of cells treated with clopidogrel in other three groups was higher than that in control group (P 〈 0. 05). The expression of Occludin in other three groups was lower than that in control group (P 〈 0.01 ). Conclusion Clopidogrel can inhibit the proliferation and induce the apoptosis of GES-1 cells. The injury mechanism of Clopidogrel in human gastric epithelial GES-1 cells may inhibit the expression of Occludin.
出处 《胃肠病学和肝病学杂志》 CAS 2013年第12期1240-1243,共4页 Chinese Journal of Gastroenterology and Hepatology
关键词 氯吡格雷 人胃黏膜上皮细胞 增殖 凋亡 Clopidogrel GES-1 Proliferation Apoptosis
  • 相关文献

参考文献20

  • 1Durand-Zaleski I,Bertrand M. The value of clopidogrel versus aspirin in reducing atherothrombotic events:the CAPRIE study[J].Pharmacogenomics,2004,(04):19-27.
  • 2Yusuf S,Zhao F,Mehta SR. Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation[J].New England Journal of Medicine,2001,(07):494-502.
  • 3Mehta SR,Yusuf S,Peters RJ. Effects of pretreatment with clopidogrel and aspirin followed by long-term therapy in patients undergoing percutaneous coronary intervention:the PCI-CURE study[J].The Lancet,2001,(9281):527-533.doi:10.1016/S0140-6736(01)05701-4.
  • 4Steinhubl SR,Berger PB,Mann JT 3rd. Early and sustained dual oral antiplatelet therapy following percutaneous coronary intervention:a randomized controlled trial[J].Journal of the American Medical Association,2002,(19):2411-2420.
  • 5Ho PM,Maddox TM,Wang L. Risk of adverse outcomes associated with concomitant use of clopidogrel and proton pump inhibitors following acute coronary syndrome[J].Journal of the American Medical Association,2009,(09):937-944.
  • 6Juurlink DN,Gomes T,Ko DT. A population-based study of the drug interaction between proton pump inhibitors and clopidogrel[J].Canadian Medical Association Journal,2009,(07):713-718.doi:10.1503/cmaj.082001.
  • 7Gilard M,Arnaud B,Le Gal G. Influence of omeprazol on the antiplatelet action of clopidogrel associated to aspirin[J].Journal of Thrombosis and Haemostasis,2006,(11):2508-2509.doi:10.1111/j.1538-7836.2006.02162.x.
  • 8Fontana P,Senouf D,Mach F. Biological effect of increased maintenance dose of clopidogrel in cardiovascular outpatients and influence of the cytochrome P450 2C19*2 allele on clopidogrel responsiveness[J].Thrombosis Research,2008,(04):463-468.doi:10.1016/j.thromres.2007.06.012.
  • 9Small DS,Farid NA,Payne CD. Effects of the proton pump inhibitor lansoprazole on the pharmacokinetics and pharmacodynamics of prasugrel and clopidogrel[J].Journal of Clinical Pharmacology,2008,(04):475-484.
  • 10孙沂,樊宏伟,王书奎,何帮顺,张振玉.氯吡格雷对人胃黏膜上皮细胞株GES-1增殖作用的影响[J].世界华人消化杂志,2010,18(4):329-334. 被引量:11

二级参考文献42

共引文献20

同被引文献33

  • 1王石健,赵瑞曼,陈旭丽.伊托必利对氯吡格雷所致胃黏膜损伤动物模型的保护作用及机制[J].中国医院药学杂志,2020,40(3):274-278. 被引量:6
  • 2Uotani T,Sugimoto M,Nishino M,et al.Ability of rabeprazole to prevent gastric mucosal damage from clopidogrel and low doses of aspirin depends on CYP2C19 genotype[J].Clin Gastroenterol Hepatol,2012,10(8):879-885.
  • 3Uotani T,Sugimoto M,Nishino M,et al.Prevention of gastric mucosal injury induced by anti-platelet drugs by famotidine[J].J Clin Pharmacol,2014,54(8):858-864.
  • 4Arbel Y,Birati EY,Finkelstein A,et al.Platelet inhibitory effect of clopidogrel in patients treated with omeprazole,pantoprazole,and famotidine:a prospective,randomized,crossover study[J].Clin Cardiol,2013,36(6):342-346.
  • 5Lin CF,Shen LJ,Wu FL,et al.Cardiovascular outcomes associated with concomitant use of clopidogrel and proton pump inhibitors in patients with acute coronary syndrome in Taiwan[J].Br J Clin Pharmacol,2012,74(5):824-834.
  • 6Hsu PI,Lai KH,Liu CP.Esomeprazole with clopidogrel reduces peptic ulcer recurrence,compared with clopidogrel alone,in patients with atheroselerosis[J].Gastroenterology,2011,140(3):791-798.
  • 7Fujisawa M,Murata T,Hori M,et al.The 5-HT4receptor agonist mosapride attenuates NSAID-induced gastric mucosal damage[J].J Gastroenterol,2010,45(2):179-186.
  • 8Oshima T,Koseki J,Chen X,et al.Acid modulates the squamous epithelial barrier function by modulating the localization of claudins in the superficial layers[J].Lab Invest,2012,92(1):22-31.
  • 9Yang R,Harada T,Li J,et al.Bile modulates intestinal epithelial barrier function via an extracellular signal related kinase 1/2 dependent mechanism[J].Intensive Care Med,2005,31(5):709-717.
  • 10Wu HL,Gao X,Jiang ZD,et al.Attenuated expression of the tight junction proteins is involved in clopidogrel-induced gastric injury through p38 MAPK activation[J].Toxicology,2013,304(2013):41-48.

引证文献3

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部